Within the INSEMA review – a prospectively randomized analyze comparing SLNE vs. no SLNE in patients with early invasive breast cancer (??5?cm, cN0) and breast-conserving therapy – information onAlthough benefits of solely retrospective research assessing gene expression signatures as prognostic and predictive parameters are promising, up to no